The American unit of German drugmaker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.
The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson’s disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label.
Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.
The company is asking health care professionals to return the products.
Was this article valuable?
Here are more articles you may enjoy.
Florida’s Heritage Insurance Reports 5,400 Claims, $57M in Cat Losses From Milton 
Program Uses AI to Send Cash Payments to 1,000 Households Hit by Hurricanes 
Spain’s Deadly Storms Move North to Cause Chaos in Catalonia 
Malibu Retrofit at $300,000 Shows Limits of Wildfire-Prepping 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.